Labrucherie Gil M — SEC insider filings

SEC reporting owner CIK 1394875. 34 insider filings on record with FilingPulse; latest filed 2026-11-18.

Transaction summary — filings shown

Covers all 34 filings on record, filed 2020-08-19 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
NEKTAR THERAPEUTICS (NKTR)SVP, COO & CFO15—17 legs · 244,439 sh · $4,262,62115
Septerna, Inc. (SEPN)Chief Financial Officer65 legs · 40,000 sh · $229,1643 legs · 20,000 sh · $832,3593
Rezolute, Inc. (RZLT)Director82 legs · 105,262 sh · $399,996—9
ACELYRIN, Inc. (SLRN)CFO and CBO5——5

Insider filings — Labrucherie Gil M

FiledFormIssuerReported transactionsSource
2026-11-184Septerna, Inc. (SEPN)Sale (S): 15,815 @ $41.48 · Sale (S): 3,485 @ $41.99 · Sale (S): 700 @ $43EDGAR
2026-02-104Septerna, Inc. (SEPN)Grant/award (A): 125,000 (derivative) @ $0EDGAR
2025-11-214Rezolute, Inc. (RZLT)Grant/award (A): 21,000 @ $0 · Grant/award (A): 12,000 (derivative) @ $0EDGAR
2025-08-114Septerna, Inc. (SEPN)Grant/award (A): 37,500 (derivative) @ $0EDGAR
2025-06-134Rezolute, Inc. (RZLT)Grant/award (A): 9,000 @ $0 · Grant/award (A): 5,000 (derivative) @ $0EDGAR
2025-02-274Septerna, Inc. (SEPN)Purchase (P): 6,282 @ $5.59 · Purchase (P): 3,718 @ $5.85EDGAR
2025-02-214Septerna, Inc. (SEPN)Purchase (P): 10,500 @ $5.51 · Purchase (P): 14,500 @ $5.88 · Purchase (P): 5,000 @ $5.85EDGAR
2025-02-204Rezolute, Inc. (RZLT)Grant/award (A): 25,500 @ $0 · Grant/award (A): 15,000 (derivative) @ $0EDGAR
2025-02-074Septerna, Inc. (SEPN)Grant/award (A): 222,000 (derivative) @ $0EDGAR
2024-09-044ACELYRIN, Inc. (SLRN)Grant/award (A): 150,000 (derivative) @ $0EDGAR
2024-05-244ACELYRIN, Inc. (SLRN)Grant/award (A): 184,042 (derivative) @ $0EDGAR
2024-01-254Rezolute, Inc. (RZLT)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2024-01-114ACELYRIN, Inc. (SLRN)Grant/award (A): 855,513 (derivative) @ $0EDGAR
2023-10-064ACELYRIN, Inc. (SLRN)Other (J): 40,763 @ $0EDGAR
2023-08-214ACELYRIN, Inc. (SLRN)Grant/award (A): 254,939 (derivative) @ $0EDGAR
2022-06-274Rezolute, Inc. (RZLT)Grant/award (A): 80,000 (derivative) @ $0EDGAR
2022-05-174NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 28,750 @ $0 · Sale (S): 17,448 @ $3.95EDGAR
2022-05-094/ARezolute, Inc. (RZLT)Purchase (P): 52,631 @ $3.80EDGAR
2022-05-064Rezolute, Inc. (RZLT)Purchase (P): 52,631 @ $3.80EDGAR
2022-02-184NEKTAR THERAPEUTICS (NKTR)Sale (S): 7,579 @ $10.95EDGAR
2021-12-204/ANEKTAR THERAPEUTICS (NKTR)Holdings only — no transactions reportedEDGAR
2021-12-204NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 52,950 @ $0 · Grant/award (A): 94,000 (derivative) @ $0EDGAR
2021-11-184NEKTAR THERAPEUTICS (NKTR)Sale (S): 21,149 @ $13.16 · Sale (S): 3,000 @ $12.69EDGAR
2021-11-174NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 40,150 @ $0EDGAR
2021-10-144NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 71,550 (derivative) @ $0EDGAR
2021-08-184NEKTAR THERAPEUTICS (NKTR)Sale (S): 7,867 @ $13.83 · Sale (S): 3,000 @ $13.56EDGAR
2021-07-144Rezolute, Inc. (RZLT)Grant/award (A): 5,000 (derivative) @ $0EDGAR
2021-05-194NEKTAR THERAPEUTICS (NKTR)Sale (S): 7,898 @ $18.30EDGAR
2021-02-184NEKTAR THERAPEUTICS (NKTR)Sale (S): 7,977 @ $22.37EDGAR
2021-02-044NEKTAR THERAPEUTICS (NKTR)Option exercise (M): 50,000 @ $8.80 · Sale (S): 41,135 @ $19.97 · Sale (S): 6,932 @ $20.96 · Sale (S): 1,933 @ $21.66 · Option exercise (M): 25,000 @ $8.80 · Option exercise (M): 25,000 @ $8.80 · +7 moreEDGAR
2020-12-224NEKTAR THERAPEUTICS (NKTR)Grant/award (A): 40,000 @ $0 · Grant/award (A): 71,500 (derivative) @ $0EDGAR
2020-11-184NEKTAR THERAPEUTICS (NKTR)Sale (S): 8,276 @ $16.93EDGAR
2020-09-214NEKTAR THERAPEUTICS (NKTR)Sale (S): 2,000 @ $19.96EDGAR
2020-08-194NEKTAR THERAPEUTICS (NKTR)Sale (S): 6,245 @ $19.67 · Sale (S): 2,000 @ $19.68EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1394875 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs